A powerful score-based statistical test for group difference in weighted biological networks

BMC Bioinformatics

Volumn 17, Issue 1, 2016, Pages

  Ji, Jiadong ^a   Yuan, Zhongshang ^a   Zhang, Xiaoshuai ^a   Xue, Fuzhong ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Network comparison; Network medicine; Score based statistical test; Systems epidemiology

Indexed keywords

BIOMOLECULES; DISEASES; GENE EXPRESSION; STATISTICAL TESTS;

BIOLOGICAL NETWORKS; GENE EXPRESSION DATA; GENE INTERACTION NETWORKS; NETWORK COMPARISONS; NETWORK MEDICINES; NETWORK PROPERTIES; NETWORK TOPOLOGY STRUCTURE; NOTCH SIGNALING PATHWAYS;

COMPLEX NETWORKS;

EPISTASIS; FEMALE; GENE REGULATORY NETWORK; GENETICS; HUMAN; LEPROSY; OVARY TUMOR; SIGNAL TRANSDUCTION; STATISTICAL MODEL;

EPISTASIS, GENETIC; FEMALE; GENE REGULATORY NETWORKS; HUMANS; LEPROSY; MODELS, STATISTICAL; OVARIAN NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84957873113     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/s12859-016-0916-x     Document Type: Article

References (37)

1. Barabasi AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet. 2011;12(1):56-68.
2. Bedelbaeva K, Snyder A, Gourevitch D, Clark L, Zhang XM, Leferovich J, et al. Lack of p21 expression links cell cycle control and appendage regeneration in mice. Proc Natl AcadSci U S A. 2010;107(13):5845-50.
3. Schadt EE. Molecular networks as sensors and drivers of common human diseases. Nature. 2009;461(7261):218-23.
4. Barabasi AL, Oltvai ZN. Network biology: understanding the cell's functional organization. Nat Rev Genet. 2004;5(2):101-13.
5. Albert R. Scale-free networks in cell biology. J Cell Sci. 2005;118(Pt 21):4947-57.
6. Wu X, Jiang R, Zhang MQ, Li S. Network-based global inference of human disease genes. Mol Syst Biol. 2008;4:189.
7. Taylor IW, Linding R, Warde-Farley D, Liu Y, Pesquita C, Faria D, et al. Dynamic modularity in protein interaction networks predicts breast cancer outcome. Nat Biotechnol. 2009;27(2):199-204.
8. Laenen G, Thorrez L, Bornigen D, Moreau Y. Finding the targets of a drug by integration of gene expression data with a protein interaction network. Mol Biosyst. 2013;9(7):1676-85.
9. Yang B, Zhang J, Yin Y, Zhang Y. Network-based inference framework for identifying cancer genes from gene expression data. Biomed Res Int. 2013;2013:401649.
10. Wu B, Li C, Du Z, Yao Q, Wu J, Feng L, et al. Network based analyses of gene expression profile of LCN2 overexpression in esophageal squamous cell carcinoma. Sci Rep. 2014;4:5403.
11. Hafeman DM, Schwartz S. Opening the Black Box: a motivation for the assessment of mediation. Int J Epidemiol. 2009;38(3):838-45.
12. Haring R, Wallaschofski H. Diving through the "-omics": the case for deep phenotyping and systems epidemiology. OMICS. 2012;16(5):231-4.
13. Lund E, Dumeaux V. Systems epidemiology in cancer. Cancer Epidemiol Biomarkers Prev. 2008;17(11):2954-7.
14. de la Fuente A. From 'differential expression' to 'differential networking' - identification of dysfunctional regulatory networks in diseases. Trends Genet. 2010;26(7):326-33.
15. Ji J, Yuan Z, Zhang X, Li F, Xu J, Liu Y, et al. Detection for pathway effect contributing to disease in systems epidemiology with a case-control design. BMJ Open. 2015;5(1):e006721.
16. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.
17. Zhang B, Li H, Riggins RB, Zhan M, Xuan J, Zhang Z, et al. Differential dependency network analysis to identify condition-specific topological changes in biological networks. Bioinformatics. 2009;25(4):526-32.
18. Valcarcel B, Wurtz P, Seicha BNK, Tukiainen T, Kangas AJ, Soininen P, et al. A differential network approach to exploring differences between biological states: an application to prediabetes. PLoS One. 2011;6(9):e24702.
19. Yates PD, Mukhopadhyay ND. An inferential framework for biological network hypothesis tests. BMC Bioinformatics. 2013;14:94.
20. Reverter A, Ingham A, Lehnert SA, Tan SH, Wang Y, Ratnakumar A, et al. Simultaneous identification of differential gene expression and connectivity in inflammation, adipogenesis and cancer. Bioinformatics. 2006;22(19):2396-404.
21. Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol. 2005;4(1):Article17.
22. Gill R, Datta S, Datta S. A statistical framework for differential network analysis from microarray data. BMC Bioinformatics. 2010;11:95.
23. Kim J, Wozniak JR, Mueller BA, Shen X, Pan W. Comparison of statistical tests for group differences in brain functional networks. Neuroimage. 2014;101:681-94.
24. Fleiss JL. On the distribution of a linear combination of independent chi squares. J Am Stat Assoc. 1971.
25. Zhang FR, Huang W, Chen SM, Sun LD, Liu H, Li Y, et al. Genomewide association study of leprosy. N Engl J Med. 2009;361(27):2609-18.
26. Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res. 2008;14(16):5198-208.
27. Fresno VJA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonzalez-Baron M. PI3K/Aktsignalling pathway and cancer. Cancer Treat Rev. 2004;30(2):193-204.
28. Rose SL. Notch signaling pathway in ovarian cancer. Int J Gynecol Cancer. 2009;19(4):564-6.
29. Groeneweg JW, Foster R, Growdon WB, Verheijen R, Rueda BR. Notch signaling in serous ovarian cancer. J Ovarian Res. 2014;7(1):95.
30. Fukushima A. DiffCorr: an R package to analyze and visualize differential correlations in biological networks. Gene. 2013;518(1):209-14.
31. Rao W, Li H, Song F, Zhang R, Yin Q, Wang Y, et al. OVA66 increases cell growth, invasion and survival via regulation of IGF-1R-MAPK signaling in human cancer cells. Carcinogenesis. 2014;35(7):1573-81.
32. Liu MX, Siu MK, Liu SS, Yam JW, Ngan HY, Chan DW. Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer. Oncotarget. 2014;5(4):944-58.
33. Wang LL, Cai HQ, Dong XQ, Zhang LW, Jiang SS, Zhao N, et al. Differentially expressed gene profiles in the serum before and after the ultrasound-guided ethanol sclerotherapy in patients with ovarian endometriomas. Clin Biochem. 2015;48(16-17):1131-7.
34. Galic V, Shawber CJ, Reeves C, Shah M, Murtomaki A, Wright J, et al. NOTCH2 expression is decreased in epithelial ovarian cancer and is related to the tumor histological subtype. Pathol Discov. 2013;1:4.
35. Kulic I, Robertson G, Chang L, Baker JH, Lockwood WW, Mok W, et al. Loss of the Notch effector RBPJ promotes tumorigenesis. J Exp Med. 2015;212(1):37-52.
36. Sinnathamby G, Zerfass J, Hafner J, Block P, Nickens Z, Hobeika A, et al. ADAM metallopeptidase domain 17 (ADAM17) is naturally processed through major histocompatibility complex (MHC) class I molecules and is a potential immunotherapeutic target in breast, ovarian and prostate cancers. Clin Exp Immunol. 2011;163(3):324-32.
37. Xiong M, Feghali-Bostwick CA, Arnett FC, Zhou X. A systems biology approach to genetic studies of complex diseases. FEBS Lett. 2005;579(24):5325-32.